绿新生物科技(01084)公布中期业绩 公司拥有人应占亏损1206.8万元 同比盈转亏

Group 1 - The core viewpoint of the article is that Green New Biotechnology (01084) reported a decline in revenue and a shift to a loss for the first half of 2025 [1] - The company's revenue for the first half of 2025 was 410 million, representing a year-on-year decrease of 10.7% [1] - The company reported a loss attributable to shareholders of 12.068 million, marking a transition from profit to loss compared to the previous year [1] Group 2 - The loss per share for the company was 0.014 [1] - The decrease in revenue was primarily attributed to a decline in both the sales volume and sales prices of carrageenan and agar during the first half of 2025 [1]